FEMSelect Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

FEMSelect Ltd. - overview

Established

2012

Location

-, -, Israel

Primary Industry

Medical Devices & Equipment

About

Founded in 2012 and based in Israel by Menahem Neuman, FEMSelect Ltd. is a developer of a pelvic floor ligament attachment method to prevent the sagging or falling of the female pelvic organs. As of 2022, Debbie Garner and Renee Selman are the co-CEOs of the company. In October 2022, FEMSelect Ltd.


raised USD 9 million in Series B funding from New Age Ventures and TriVentures, including Keiretsu Capital, Keiretsu Forum Mid-Atlantic, MEDA Angels, RAD BioMed, Robin Hood Ventures, and TransPacific Venture Partners. The company also has an office in the US. The company offers EnPlace®, a delivery technology that allows for precise guidance, insertion, and deployment of the anchor unit. EnPlace® is a minimally invasive surgical system that does not require any deep dissection or mesh and is made up of a Nitinol-based anchor, surgical sutures, and a unique attaching mechanism.


The organization plans to use the October 2022 funding to accelerate EnPlace®, primarily in the US, and to support its growth.


Current Investors

Mid Atlantic Bio Angels, Robin Hood Ventures, Triventures

Primary Industry

Medical Devices & Equipment

Sub Industries

Healthcare, Surgical Devices

Website

www.femselect.com

Verticals

Manufacturing

Company Stage

Series B

Total Amount Raised

Subscriber access only

FEMSelect Ltd. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.